BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Pharm Country

  Anavex Life Sciences to Present at the 11th Annual SVB Leerink Global Healthcare Conference

  Anavex Life Sciences Corp. announced that Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex, will participate in the virtual 11th Annual SVB Leerink Global Healthcare Conference and present on Wednesday, February 16 at 3 pm ET.

  February 10, 2022

   · 

  3 min read
• Business

  Atea Pharmaceuticals Appoints Nancy Gail Berry Agrawal, Ph.D., as Executive Vice President of Preclinical Development

  Atea Pharmaceuticals, Inc. today announced the appointment of Nancy Gail Berry Agrawal, Ph.D., as Executive Vice President of Preclinical Development.

  February 10, 2022

   · 

  4 min read
• Genetown

  Surface Oncology to Participate in Citi’s 2022 Virtual Immuno-Oncology Summit

  Surface Oncology, a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, announced that company management will participate in a fireside chat during Citi’s 2022 Virtual Immuno-Oncology Summit.

  February 10, 2022

   · 

  1 min read
• BioMidwest

  Miromatrix to Ring Nasdaq Closing Bell on National Donor Day, February 14, 2022

  Miromatrix Medical Inc. announced that the Company will ring the closing bell at Nasdaq on Monday, February 14, 2022, at 4:00 p.m. ET to celebrate National Donor Day and the Company’s public listing last year on Nasdaq under the trading symbol MIRO.

  February 10, 2022

   · 

  4 min read
• Genetown

  Arkuda Therapeutics Raises $64 Million Series B Financing to Advance Pipeline of Programs Targeting Lysosomal Biology to Treat Neurodegenerative Diseases

  Arkuda Therapeutics today announced the completion of a $64 million Series B financing.

  February 10, 2022

   · 

  4 min read
• Business

  GentiBio Appoints Industry Veteran Chuck Silberstein as Chief Financial Officer

  GentiBio, Inc. today announced the appointment of Chuck Silberstein , M.D., MBA, as Chief Financial Officer (CFO).

  February 10, 2022

   · 

  2 min read
• Biotech Bay

  Protagonist Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference

  Protagonist Therapeutics announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will present virtually at the 11th Annual SVB Leerink Global Healthcare Conference on February 17th at 3:00 p.m. EST.

  February 10, 2022

   · 

  1 min read
• Business

  Ionis to hold full year 2021 financial results webcast

  Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Thursday, February 24th at 11:30 a.m. Eastern Time to discuss its fourth quarter and full year 2021 financial results as well as report on pipeline and business progress.

  February 10, 2022

   · 

  1 min read
• Business

  Orthofix Medical Schedules Fourth Quarter and Full Year Earnings Release and Conference Call for February 25, 2022

  Orthofix Medical Inc. today announced that it plans to release financial results for the fourth quarter and full year 2021 before market open on Friday, February 25, 2022.

  February 10, 2022

   · 

  1 min read
• Genetown

  Enanta Pharmaceuticals to Present at the SVB Leerink 11th Annual Global Healthcare Conference

  Enanta Pharmaceuticals, Inc. announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the SVB Leerink 11th Annual Global Healthcare Conference on Thursday, February 17, 2022 at 3:00 p.m. ET.

  February 10, 2022

   · 

  1 min read